Bonus Episode
Spotlight on Non-Small Cell Lung Cancer (NSCLC)
In this episode, sponsored by The Janssen Pharmaceutical Companies of Johnson & Johnson, Jonathan sits down with Dr Marina Garassino, Chair of Thoracic Oncology at the National Cancer Institute of Milan, to explore the unmet needs for patients living with EGFR-mutated non-small cell lung cancer (NSCLC). They shine a light on the role played by EGFR mutations in NSCLC, the need for improved testing, and the importance of engagement of both doctors and patients for shaping clinical decisions.
